C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/02 (2006.01) A61K 9/19 (2006.01) A61K 39/265 (2006.01) A61K 39/295 (2006.01) A61K 47/46 (2006.01) C07K 14/06 (2006.01) C12N 7/04 (2006.01) C12N 15/01 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2141392
Infectious Bovine Rhinotracheitis Virus mutant, methods for the production of same, and vaccines containing the same. The obtained virus, characterized as BHV-1 FM gll-, results from one deletion, from one insertion, or from one substitution (deletion and insertion) in the gene gll (gE) from Bovine Herpesvirus type 1 (BHV-1), which fails to produce any antigenic polypeptide of glycoprotein gll (gE). BHV-1 FM gll- virus is utilized in the preparation of vaccines for Infectious Bovine Rhinotracheitis. These vaccines allow to distinguish serologically between animals vaccinated with the same and animals infected with field strains of IBR virus.
Lloberas Jorge
Perez-Pons Josep Anton
Pinol Jaume
Querol Enrique
Rebordosa Xavier
Fetherstonhaugh & Co.
Laboratorios Hipra S.a.
LandOfFree
Recombinant infectious bovine rhinotracheitis virus mutant,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant infectious bovine rhinotracheitis virus mutant,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant infectious bovine rhinotracheitis virus mutant,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1536637